Gary E. Wild
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
The Association of Faecal Calprotectin Measurements With Endo-Histological Remission in Ulcerative Colitis: A Pooled Analysis.
Journal: Alimentary pharmacology & therapeutics
Published: January 05, 2026
Clinical outcomes and drug sustainability after non-medical switch from ustekinumab originator to biosimilars in inflammatory bowel disease.
Journal: World journal of gastroenterology
Published: September 17, 2025
The Role of Biomarkers in Surveillance of Ulcerative Colitis-Associated Colorectal Cancer: A Scoping Review.
Journal: Journal of clinical medicine
Published: July 21, 2025
Assessing the role of ustekinumab dose escalation in Crohn's disease patients with loss of response: an observational study.
Journal: Journal of the Canadian Association of Gastroenterology
Published: June 26, 2025
Impact of Individual Colonic Segment Histological Activity on Disease Relapse in Patients with Ulcerative Colitis.
Journal: Journal of clinical medicine
Published: June 10, 2025
Defining Fecal Calprotectin Cutoffs That Predict Endoscopic and Histologic Remission in Patients With Ulcerative Colitis.
Journal: Inflammatory bowel diseases
Published: September 25, 2024
Association Between Serum Ustekinumab Concentrations and Endoscopic Disease Activity in Moderate-to-Severe Crohn's Disease Patients.
Journal: Crohn's & colitis 360
Published: July 04, 2024
Clinical efficacy and nocebo effect following non-medical biosimilar switch in patients with inflammatory bowel disease: A prospective observational study.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: May 10, 2023
Mucosal Healing and Clinical Efficacy of Adalimumab in Small Intestinal Crohn's Disease (SIMCHA Study): Final Results From a Prospective, Open-Label, Single-Arm Study.
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: May 10, 2023
Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases.
Journal: Crohn's & colitis 360
Published: November 15, 2022
Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
Journal: Journal of clinical medicine
Published: June 28, 2022
Adherence to Objective Therapeutic Monitoring and Outcomes in Patients with Inflammatory Bowel Disease with Adalimumab Treatment. A Real-world Prospective Study.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: May 17, 2022
Last Updated: 09/26/2026